Your browser doesn't support javascript.
loading
A case of metastatic Xp11.2 translocation renal cell carcinoma showing a prolonged response to nivolumab as 6th-line treatment.
Yoshida, Takashi; Tanaka, Toshiaki; Shindo, Tetsuya; Kyoda, Yuki; Hashimoto, Kohei; Kobayashi, Ko; Hasegawa, Tadashi; Masumori, Naoya.
Afiliación
  • Yoshida T; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Tanaka T; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Shindo T; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Kyoda Y; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Hashimoto K; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Kobayashi K; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Hasegawa T; Department of Surgical Pathology, Sapporo Medical University, Sapporo, Japan.
  • Masumori N; Department of Urology, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
Int Cancer Conf J ; 11(2): 134-137, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35402130

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int Cancer Conf J Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int Cancer Conf J Año: 2022 Tipo del documento: Article